Actos
Pioglitazone 15mg and 30mg tablets, used in the treatment of type two diabetes. A thiazolidinedione.
- Category
- Diabetes Management
- Active ingredient
- Pioglitazone
- Route
- Oral
- Form
- Tablet
- Strengths
- 15/30mg
You will receive a quality generic equivalent, depending on stock.
Shipped in a discreet, unmarked envelope.
Details
- Conditions
- Type two diabetes
- Therapeutic Class
- Thiazolidinedione
- Pharmacological Class
- Insulin sensitizer
- Minor Side Effects
- Weight gain, Mild swelling
- Moderate Side Effects
- Headache, Upper respiratory infections
- Dosage Forms
- Tablet
- Administration Route
- Oral
- Originator
- Takeda
- Onset Time
- Weeks
- Duration
- 24 hours
- Storage Instructions
- Store in a dry place protected from humidity.
- Drug Interactions
- Insulin, Gemfibrozil
- Age Restrictions
- Not for children.
What you will receive
Actos is the originator brand name, made by Takeda. We use it to identify the medicine; the pack you receive is a generic equivalent, not the original Actos.
- The same active ingredient (Pioglitazone) at the same strength.
- The exact brand supplied depends on what is in stock when your order ships.
FAQ
Which generic Actos strengths and pack sizes can I order?
Generic Actos comes as tablets in 15mg and 30mg strengths. The 15mg packs range from 30 to 360 tablets, while 30mg packs range from 10 to 360 tablets. You receive generic pioglitazone, not the original Actos. The page shows the price per tablet in Hong Kong dollars, and larger packs cost less per tablet.
How is generic Actos shipped to Hong Kong for long-term use?
For long-term generic Actos orders, tracked courier takes 5 to 9 business days with online tracking. Standard airmail takes 14 to 21 business days, up to 30, and is untracked. Very large orders may be split into several parcels.
Do formulation variances impact activity?
Excipients-the inactive components-vary by manufacturer, yet these components do not alter the pharmacological action of the Pioglitazone molecule.
What determines the stability of the compound?
Controlled manufacturing environments maintain the chemical integrity of the tablet until the expiration date under recommended storage conditions.
Will this compound trigger positive results on drug tests?
Diabetes management compounds consist of non-controlled metabolic agents that generally do not interfere with standard workplace or athletic substance screening protocols.
About Actos
Pharmacological Identification of Generic Actos
Generic Actos (Pioglitazone) manifests as an oral therapeutic analogue designed for glycaemic management. Available concentrations include standard 15mg and 30mg tablets. This multi-source formulation mirrors the pharmacokinetic properties of the reference pharmaceutical within the diabetes management category.
The active ingredient, Pioglitazone, functions as a thiazolidinedione derivative to support metabolic regulation in patients with documented diagnoses.
Biological Mechanism of Pioglitazone
Pioglitazone acts directly on the peroxisome proliferator-activated receptor-gamma (PPAR-gamma). Activation of this nuclear receptor modulates the transcription of various insulin-responsive genes involved in glucose and lipid metabolism.
The compound increases insulin sensitivity by enhancing glucose uptake in peripheral skeletal muscle and adipose tissue. It also reduces hepatic glucose output by inhibiting gluconeogenesis. The medication does not stimulate insulin secretion from pancreatic beta cells, thereby minimizing the probability of hypoglycaemia when used as monotherapy.
Clinical Indications and Governance
Indications involve the treatment of specific metabolic dysfunctions where insulin sensitivity reduction serves as the primary pathophysiology. Healthcare providers evaluate the necessity of this therapeutic analogue based on established clinical guidelines and individual patient profiles.
Contraindications
Pregnancy and Developmental Risks
Data categorizes Pioglitazone as a pharmaceutical requiring caution throughout pregnancy. Pharmacodynamic effects on foetal development demand a consultation with a qualified obstetrician or endocrinologist before initiation.
Congestive Heart Failure
Initiation remains contraindicated in patients presenting with New York Heart Association (NYHA) Class III or IV cardiac status. Fluid retention potential complicates underlying cardiac insufficiency.
Hepatic Impairment
Evaluation of baseline liver transaminase levels occurs prior to therapy. The presence of active hepatic disease prevents the appropriate use of this compound.
Adverse Events
Common
Reported manifestations include peripheral oedema, weight gain, and upper respiratory tract infections. These clinical signs occur frequently within cohorts receiving thiazolidine derivatives.
Serious
Cases involving macular oedema or bone fractures represent clinical events requiring immediate physician reassessment. Potential for bladder neoplasia necessitates monitoring for haematuria or bladder irritation symptoms.
Interactions
Concomitant use of insulin increases the risk of congestive heart failure. Inhibitors or inducers of the CYP2C8 enzyme pathway modify the plasma concentration of the active compound.
Routes of Administration
Administered orally via tablets. Daily frequency and total quantity strictly follow the instructions provided by a qualified medical practitioner.
Storage Requirements
Maintain tablets in a room-temperature environment away from direct light and moisture. Dispose of outdated or unused units through medical waste receptacles or community pharmacy take-back programmes.
Pharmacological Glossary
PPAR-gamma: A nuclear receptor that regulates transcription of genes involved in glucose and lipid storage.
Gluconeogenesis: The metabolic process through which the liver generates glucose from non-carbohydrate substrates.
Thiazolidinedione: A class of pharmacological agents that improve insulin sensitivity by modulating nuclear receptor activity.
Sources
- Pioglitazone 15 mg Tablets - Summary of Product Characteristics — Electronic Medicines Compendium (emc)
- Type 2 Diabetes - NIDDK — NIDDK / NIH